DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Zepbound (tirzepatide) for chronic weight management, OSA with obesity. Covered with PA under Kaiser Permanente.
Kaiser is an integrated payer-provider system. Coverage decisions are made through internal formulary committees with their own evidence reviews.
BMI ≥ 30 or BMI ≥ 27 with comorbidity. OSA pathway available.
LillyDirect $349-499/mo.
Kaiser added Zepbound to formulary 2024. Approval easier with KP weight-loss program participation.
Editorial summary, not legal or medical advice. Insurance formularies change quarterly. Verify with your specific plan member services before relying on any single source. Copay ranges reflect typical commercial plans; your plan may differ.